Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jenaya Rickard"'
Autor:
Lara J. Wolfson, Maria Esther Castillo, Norberto Giglio, Zsofia Meszner, Zsuzsanna Molnar, Mirella Vazquez, Jacek Wysocki, Alexandra Altland, Barbara J. Kuter, Jenaya Rickard, Emmanouil Rampakakis
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 932-941 (2019)
Varicella is a mild and self-limited illness in children, but can result in significant healthcare resource utilization (HCRU). To quantify/contrast varicella-associated HCRU in five middle-income countries (Hungary, Poland, Argentina, Mexico, and Pe
Externí odkaz:
https://doaj.org/article/82b2e376f742422f8b4dac0c583a42fc
Autor:
John S. Sampalis, Eliofotisti Psaradellis, Melissa Stutz, Jenaya Rickard, Emmanouil Rampakakis
Publikováno v:
Drugs in R&D, Vol 18, Iss 4, Pp 283-293 (2018)
Abstract Background and Objectives Management of hypertension and dyslipidemia is important when considering cardiovascular disease risk; however, achievement of optimal lipid and blood pressure (BP) targets in clinical practice remains inadequate. T
Externí odkaz:
https://doaj.org/article/1b57438c414d4797bfc8342869f5aaec
Autor:
Jacek Wysocki, Barbara J. Kuter, Maria E. Castillo, Zsófia Mészner, Alexandra Altland, Norberto Giglio, Jenaya Rickard, Emmanouil Rampakakis, Lara J. Wolfson, Zsuzsanna Molnár, Mirella Vazquez
Publikováno v:
Human Vaccines & Immunotherapeutics
Varicella is a mild and self-limited illness in children, but can result in significant healthcare resource utilization (HCRU). To quantify/contrast varicella-associated HCRU in five middle-income countries (Hungary, Poland, Argentina, Mexico, and Pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b38f75a55137a1a48bad935894a471
http://europepmc.org/articles/PMC6605820
http://europepmc.org/articles/PMC6605820
Autor:
Jenaya Rickard, Emmanouil Rampakakis, John S. Sampalis, Melissa Stutz, Eliofotisti Psaradellis
Publikováno v:
Drugs in R&D, Vol 18, Iss 4, Pp 283-293 (2018)
Drugs in R&D
Drugs in R&D
Background and Objectives Management of hypertension and dyslipidemia is important when considering cardiovascular disease risk; however, achievement of optimal lipid and blood pressure (BP) targets in clinical practice remains inadequate. This analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7f961a6a1c9868ce00df89ea21874c
https://doi.org/10.1007/s40268-018-0255-7
https://doi.org/10.1007/s40268-018-0255-7